Diagnostic abnormalities, disease severity and immunotherapy responsiveness in individuals with Down syndrome regression disorder
Open Access
- 28 December 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Abstract
Introduction: Down Syndrome Regression Disorder (DSRD) is a neuropsychiatric condition causing insomnia, catatonia, encephalopathy, and obsessive-compulsive behavior in otherwise healthy individuals with Down syndrome (DS). Smaller cohorts have identified heterogenous diagnostic abnormalities which have predicted immunotherapy responsiveness although pattern analysis in a large cohort has never been performed. Methods: A multi-center, retrospective study of individuals with DSRD was performed. Individuals met international consensus criteria for DRSD and were aged 10–30 years. Clinical, demographic, and diagnostic data was extracted for all individuals. Serum studies were compared to a group of individuals with DS only. Results: A total of 164 individuals with DSRD were identified. Individuals with DSRD were more likely to have a positive antinuclear antibody, low complement 3, abnormal cytokines, and elevated ferritin levels. In a minority of individuals, EEG (30%), MRI (33%) and cerebrospinal fluid (CSF) (21%) were abnormal. Individuals with CSF abnormalities demonstrated greater disease severity at diagnosis on the BFCRS and NPI-Q (p = 0.02 and p < 0.001). Abnormalities in cytokines (p = 0.03), neuroimaging (p < 0.001), and CSF (p = 0.02) were predictive of immunotherapy responsiveness. When MRI and LP were both abnormal or when EEG, MRI and LP were all abnormal, the odds of immunotherapy responsiveness approached 100% (p = 0.01, 95%CI: 1.75–105.1, OR: 13.56 and p = 0.02, 95%CI: 1.37–86.87, OR: 10.91, respectively). Conclusions: In a population of individuals diagnosed with DSRD, abnormalities in serum cytokine levels, neuroimaging findings, and CSF analysis emerged as indicators of disease severity and responsiveness to immunotherapy.Keywords
This publication has 45 references indexed in Scilit:
- Alternative Diagnoses in the Work Up of Down Syndrome Regression DisorderJournal of Autism and Developmental Disorders, 2023
- Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorderTranslational Psychiatry, 2023
- Unexplained regression in Down syndrome: Management of 51 patients in an international patient databaseAmerican Journal of Medical Genetics Part A, 2022
- Paraclinical serum markers as aids in the diagnosis of autoimmune encephalitisJournal of Neuroimmunology, 2020
- Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeCell Reports, 2019
- EEG analysis in anti-NMDA receptor encephalitis: Description of typical patternsClinical Neurophysiology, 2019
- Phenotypic and Molecular Spectrum of Aicardi-Goutières Syndrome: A Study of 24 PatientsPediatric Neurology, 2018
- Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United StatesAmerican Journal of Medical Genetics Part A, 2015
- Intravenous immunoglobulin in neurology—mode of action and clinical efficacyNature Reviews Neurology, 2015
- Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complicationsDiabetic Medicine, 1998